These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7471616)

  • 1. Early hemodynamic and humoral effects of lofexidine.
    Fouad FM; Vidt DG; Williams H; Tarazi RC; Bravo EL
    Clin Pharmacol Ther; 1981 Apr; 29(4):498-504. PubMed ID: 7471616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effects of lofexidine in patients with essential hypertension.
    Fagan TC; Bloomfield SS; Cowart TD; Corns-Hurwitz RH; Lipicky RJ; Conradi EC; Hsu CY; Grossman WJ; Harmon GE; Degenhart WJ; Sinkfield AW; Gaffney TE
    Br J Clin Pharmacol; 1982 Mar; 13(3):405-10. PubMed ID: 7059442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centrally acting antihypertensive agents: a comparison of lofexidine with clonidine.
    Schultz HS; Chretien SD; Brewer DD; Eltorai MI; Weber MA
    J Clin Pharmacol; 1981; 21(2):65-71. PubMed ID: 7229119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
    Fouad FM; Tarazi RC; Bravo EL; Textor SC
    Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lofexidine and clonidine in moderate essential hypertension.
    Wilkins LH; Winternitz SR; Oparil S; Smith LR; Dustan HP
    Clin Pharmacol Ther; 1981 Dec; 30(6):752-07. PubMed ID: 7030578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal experiments on the cardiovascular effects of lofexidine.
    Graf E; Doppelfeld IS; Prop G
    Arzneimittelforschung; 1982; 32(8a):941-55. PubMed ID: 6890368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effect of lofexidine with a diuretic in hypertension.
    Vlachakis ND; Velasquez M; Alexander N; Maronde RF
    Clin Pharmacol Ther; 1983 Dec; 34(6):764-9. PubMed ID: 6357591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous and oral clonidine on hemodynamic and plasma-catecholamine response due to endotracheal intubation.
    Zalunardo MP; Zollinger A; Spahn DR; Seifert B; Radjaipour M; Gautschi K; Pasch T
    J Clin Anesth; 1997 Mar; 9(2):143-7. PubMed ID: 9075040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and cardiac hemodynamic interactions between clonidine and minoxidil.
    Velasco M; Andrews-Figueroa P; Ramiŕez A; Morillo J; Urbina-Quintana A; Aliendres R; Hernańdez-Pieretti O
    Clin Pharmacol Ther; 1981 Aug; 30(2):158-63. PubMed ID: 7249499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic hypovolemia.
    Fouad FM; Tadena-Thome L; Bravo EL; Tarazi RC
    Ann Intern Med; 1986 Mar; 104(3):298-303. PubMed ID: 3511818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in cardiac function after effective treatment of hypertensive emergencies with i.v. clonidine.
    Masotti G; Scarti L; Poggesi L; Bisi G; Gallini C; Neri Serneri GG
    Eur Heart J; 1984 Dec; 5(12):1036-42. PubMed ID: 6534750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential hypertension: hemodynamic and therapeutic changes over 20 years.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S1-7. PubMed ID: 1721971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and cognitive effects of lofexidine and methadone coadministration: a pilot study.
    Schroeder JR; Schmittner J; Bleiberg J; Epstein DH; Krantz MJ; Preston KL
    Pharmacotherapy; 2007 Aug; 27(8):1111-9. PubMed ID: 17655511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic and hemodynamic effects of chronic oral therapy with the alpha 2-agonists clonidine and tiamenidine in hypertensive volunteers.
    Roden DM; Nadeau JH; Primm RK
    Clin Pharmacol Ther; 1988 Jun; 43(6):648-54. PubMed ID: 2897889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects.
    Dollery CT; Reid JL
    Arzneimittelforschung; 1982; 32(8a):984-7. PubMed ID: 6890374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in blood pressure, plasma catecholamines and plasma renin activity during and after treatment with tiamenidine and clonidine.
    Hansson BG; Hökfelt B
    Br J Clin Pharmacol; 1981 Jan; 11(1):73-7. PubMed ID: 7011348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension.
    Muiesan G; Agabiti-Rosei E; Castellano M; Alicandri CL; Corea L; Fariello R; Beschi M; Romanelli G
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S325-9. PubMed ID: 6184562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term hemodynamic and metabolic effects of trimazosin in essential hypertension.
    Chrysant SG; Miller RF; Brown JL; Danisa K
    Clin Pharmacol Ther; 1981 Nov; 30(5):600-4. PubMed ID: 7028356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.